New state generics complaint is tougher on execs
Forty four states have sued 20 of the largest generic drugmakers – particularly targeting Teva Pharmaceuticals – alleging price manipulation, restraint of trade and other antitrust violations.
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10